Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene

Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene

US Patent 7214368 · Granted May 8, 2007

Estimated economic value: $5,748,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Use of a VEGF antagonist to treat angiogenic eye disorders2021
Compositions comprising IL6R antibodies for the treatment of uveitis and macular2021
Method for preventing metalorganic precursor penetration into porous dielectrics2007
Method to improve barrier layer adhesion2004